{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T00:25:34Z","timestamp":1792801534075,"version":"4.5.0"},"reference-count":84,"publisher":"Elsevier","isbn-type":[{"value":"9780443431722","type":"print"}],"license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026]]},"DOI":"10.1016\/bs.vh.2025.10.005","type":"book-chapter","created":{"date-parts":[[2026,2,16]],"date-time":"2026-02-16T20:33:28Z","timestamp":1771274008000},"page":"195-234","source":"Crossref","is-referenced-by-count":1,"title":["Gigantism"],"prefix":"10.1016","author":[{"given":"Sara","family":"Donato","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catarina","family":"Regala","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pedro","family":"Marques","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"8","key":"10.1016\/bs.vh.2025.10.005_bib0001","doi-asserted-by":"crossref","first-page":"2960","DOI":"10.1210\/jc.2005-2661","article-title":"Pegvisomant for the treatment of GSP-mediated growth hormone excess in patients with McCune-Albright syndrome","volume":"91","author":"Akintoye","year":"2006","journal-title":"J Clin Endocrinol Metab"},{"issue":"6","key":"10.1016\/bs.vh.2025.10.005_bib0002","doi-asserted-by":"crossref","first-page":"R339","DOI":"10.1530\/EJE-16-1054","article-title":"Management of endocrine disease: Diagnostic and therapeutic approach of tall stature","volume":"176","author":"Albuquerque","year":"2017","journal-title":"Eur J Endocrinol"},{"issue":"5","key":"10.1016\/bs.vh.2025.10.005_bib0003","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1007\/s11102-024-01461-5","article-title":"Efficacy and safety of pasireotide in acromegaly: Meta-analysis","volume":"27","author":"Aliyeva","year":"2024","journal-title":"Pituitary"},{"issue":"2","key":"10.1016\/bs.vh.2025.10.005_bib0004","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1007\/s11102-006-9330-0","article-title":"Acromegaloidism with normal growth hormone secretion associated with X-tetrasomy","volume":"9","author":"Alvarez-V\u00e1zquez","year":"2006","journal-title":"Pituitary"},{"issue":"1","key":"10.1016\/bs.vh.2025.10.005_bib0005","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1007\/s12022-022-09742-0","article-title":"The spectrum of familial pituitary neuroendocrine tumors","volume":"34","author":"Armeni","year":"2023","journal-title":"Endocr Pathol"},{"issue":"3","key":"10.1016\/bs.vh.2025.10.005_bib0006","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1530\/EJE-21-0729","article-title":"Long-term outcomes of acromegaly: Swedish register","volume":"186","author":"Arnard\u00f3ttir","year":"2022","journal-title":"Eur J Endocrinol"},{"issue":"3","key":"10.1016\/bs.vh.2025.10.005_bib0007","doi-asserted-by":"crossref","first-page":"416","DOI":"10.4183\/aeb.2019.416","article-title":"Williams textbook of Endocrinology \u2013 14th revised edition","volume":"15","author":"Badiu","year":"2019","journal-title":"Acta Endocrinol (Buchar)"},{"issue":"2","key":"10.1016\/bs.vh.2025.10.005_bib0008","doi-asserted-by":"crossref","DOI":"10.1016\/j.beem.2019.05.002","article-title":"Modern imaging of pituitary adenomas","volume":"33","author":"Bashari","year":"2019","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"issue":"12","key":"10.1016\/bs.vh.2025.10.005_bib0009","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1038\/s41574-018-0114-1","article-title":"The causes and consequences of pituitary gigantism","volume":"14","author":"Beckers","year":"2018","journal-title":"Nat Rev Endocrinol"},{"key":"10.1016\/bs.vh.2025.10.005_bib0010","series-title":"StatPearls","article-title":"Gigantism and acromegaly","author":"Bello","year":"2025"},{"issue":"4","key":"10.1016\/bs.vh.2025.10.005_bib0012","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1159\/000369802","article-title":"Endocrine implications of neurofibromatosis 1 in childhood","volume":"83","author":"Bizzarri","year":"2015","journal-title":"Horm Res Paediatr"},{"issue":"6","key":"10.1016\/bs.vh.2025.10.005_bib0013","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1542\/peds.83.6.998","article-title":"Acromegaly in an infant","volume":"83","author":"Blumberg","year":"1989","journal-title":"Pediatrics"},{"issue":"7","key":"10.1016\/bs.vh.2025.10.005_bib0014","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.3390\/jcm10071377","article-title":"Genetics of acromegaly and gigantism","volume":"10","author":"Bogus\u0142awska","year":"2021","journal-title":"J Clin Med"},{"issue":"6","key":"10.1016\/bs.vh.2025.10.005_bib0015","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1016\/j.ando.2012.09.004","article-title":"Acromegaly induced by ectopic secretion of GHRH: A review 30 years after GHRH discovery","volume":"73","author":"Borson-Chazot","year":"2012","journal-title":"Ann endocrinol (Paris)"},{"issue":"2","key":"10.1016\/bs.vh.2025.10.005_bib0016","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1016\/j.ecl.2016.02.004","article-title":"Advances in imaging of the pediatric pituitary gland","volume":"45","author":"Bou-Ayache","year":"2016","journal-title":"Endocrinol Metab Clin North Am"},{"issue":"8","key":"10.1016\/bs.vh.2025.10.005_bib0017","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1016\/S2213-8587(25)00119-6","article-title":"Multiple endocrine neoplasia type 1 (MEN1): Recommendations and guidelines for best practice","volume":"13","author":"Brandi","year":"2025","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"9","key":"10.1016\/bs.vh.2025.10.005_bib0018","doi-asserted-by":"crossref","first-page":"2353","DOI":"10.1002\/ajmg.a.38308","article-title":"Growth hormone excess in children with neurofibromatosis type 1 and optic glioma","volume":"173","author":"Cambiaso","year":"2017","journal-title":"Am J Med Genet A"},{"issue":"3","key":"10.1016\/bs.vh.2025.10.005_bib0019","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1210\/clinem\/dgaa859","article-title":"Discordant GH\/IGF-1 in treated acromegaly","volume":"106","author":"Campana","year":"2021","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"10.1016\/bs.vh.2025.10.005_bib0020","first-page":"29","article-title":"Diagnosis and management of acromegaly: A consensus statement","volume":"20","author":"Cardoso","year":"2025","journal-title":"Endocrinol Insights"},{"issue":"3","key":"10.1016\/bs.vh.2025.10.005_bib0021","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1054\/clnu.2001.0397","article-title":"IGF-1, a nutritional marker in patients with eating disorders","volume":"20","author":"Caregaro","year":"2001","journal-title":"Clin Nutr"},{"key":"10.1016\/bs.vh.2025.10.005_bib0022","unstructured":"Carreira A.L., Korbonits M. Familial isolated pituitary adenoma [Internet]. 2024 [cited 2025 Jul 15]. Available from: https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK278949\/."},{"key":"10.1016\/bs.vh.2025.10.005_bib0023","doi-asserted-by":"crossref","DOI":"10.1136\/bcr-2016-214493","article-title":"Pseudoacromegaly in congenital generalised lipodystrophy (Berardinelli-Seip syndrome)","volume":"2016","author":"Chakraborty","year":"2016","journal-title":"BMJ Case Rep"},{"issue":"2","key":"10.1016\/bs.vh.2025.10.005_bib0024","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1007\/BF03347049","article-title":"Biochemical control and adenoma disappearance in child with gigantism","volume":"34","author":"Ciresi","year":"2011","journal-title":"J Endocrinol Invest"},{"issue":"2","key":"10.1016\/bs.vh.2025.10.005_bib0025","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.ando.2017.04.006","article-title":"How to investigate a child with excessive growth?","volume":"78","author":"Coutant","year":"2017","journal-title":"Ann endocrinol(Paris)"},{"issue":"8","key":"10.1016\/bs.vh.2025.10.005_bib0026","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1210\/js.2017-00164","article-title":"Pseudoacromegaly: A differential diagnostic problem for acromegaly with a genetic solution","volume":"1","author":"Dahlqvist","year":"2017","journal-title":"J Endocr Soc"},{"issue":"5","key":"10.1016\/bs.vh.2025.10.005_bib0027","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1210\/endrev\/bnae014","article-title":"The genetic pathophysiology and clinical management of the TADopathy, X-linked acrogigantism","volume":"45","author":"Daly","year":"2024","journal-title":"Endocr Rev"},{"key":"10.1016\/bs.vh.2025.10.005_bib0028","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2023.1305606","article-title":"PAM variants in patients with thyrotrophinomas, cyclical Cushing's disease and prolactinomas","volume":"14","author":"De Sousa","year":"2023","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"2","key":"10.1016\/bs.vh.2025.10.005_bib0029","doi-asserted-by":"crossref","first-page":"287","DOI":"10.3171\/jns.2002.97.2.0287","article-title":"GH and IGF-I after pituitary surgery","volume":"97","author":"Espinosa-de-los-Monteros","year":"2002","journal-title":"J Neurosurg"},{"issue":"12","key":"10.1016\/bs.vh.2025.10.005_bib0030","doi-asserted-by":"crossref","first-page":"6480","DOI":"10.1210\/jc.2005-0901","article-title":"Postoperative evaluation in acromegaly","volume":"90","author":"Feelders","year":"2005","journal-title":"J Clin Endocrinol Metab"},{"issue":"4","key":"10.1016\/bs.vh.2025.10.005_bib0031","first-page":"1357","article-title":"GH hypersecretion in McCune-Albright syndrome","volume":"80","author":"Feuillan","year":"1995","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"10.1016\/bs.vh.2025.10.005_bib0032","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s11102-020-01091-7","article-title":"Pituitary Society update to acromegaly guidelines","volume":"24","author":"Fleseriu","year":"2021","journal-title":"Pituitary"},{"issue":"11","key":"10.1016\/bs.vh.2025.10.005_bib0033","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1016\/S2213-8587(22)00244-3","article-title":"Acromegaly: Pathogenesis, diagnosis, and management","volume":"10","author":"Fleseriu","year":"2022","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"2","key":"10.1016\/bs.vh.2025.10.005_bib0034","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1111\/j.1365-2265.2009.03556.x","article-title":"Monitoring acromegaly: GH and IGF-1 discrepancies","volume":"71","author":"Freda","year":"2009","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"1","key":"10.1016\/bs.vh.2025.10.005_bib0035","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1007\/s11102-017-0789-7","article-title":"The genetic background of acromegaly","volume":"20","author":"Gadelha","year":"2017","journal-title":"Pituitary"},{"issue":"1","key":"10.1016\/bs.vh.2025.10.005_bib0036","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1186\/s13052-022-01242-5","article-title":"Current clinical management of constitutional delay of growth and puberty","volume":"48","author":"Gaudino","year":"2022","journal-title":"Ital J Pediatr"},{"key":"10.1016\/bs.vh.2025.10.005_bib0037","series-title":"Endotext","article-title":"Pituitary gigantism","author":"George","year":"2000"},{"issue":"1","key":"10.1016\/bs.vh.2025.10.005_bib0038","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1007\/s11102-023-01360-1","article-title":"Consensus on criteria for acromegaly diagnosis and remission","volume":"27","author":"Giustina","year":"2024","journal-title":"Pituitary"},{"issue":"8","key":"10.1016\/bs.vh.2025.10.005_bib0039","doi-asserted-by":"crossref","first-page":"2953","DOI":"10.1210\/jc.2007-2283","article-title":"Pegvisomant for pituitary gigantism","volume":"93","author":"Goldenberg","year":"2008","journal-title":"J Clin Endocrinol Metab"},{"issue":"11","key":"10.1016\/bs.vh.2025.10.005_bib0040","first-page":"e2009","article-title":"Genetic testing of children with familial tall stature: Is it worth doing?","volume":"109","author":"Gregorova","year":"2024","journal-title":"J Clin Endocrinol Metab"},{"issue":"3","key":"10.1016\/bs.vh.2025.10.005_bib0041","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1007\/s12020-025-04186-y","article-title":"Expanding the phenotype of multiple endocrine neoplasia type 5 (MEN5): Pituitary gigantism, myelolipoma and familial pheochromocytoma due to a germline pathogenic MAX variant","volume":"88","author":"Haider","year":"2025","journal-title":"Endocrine"},{"issue":"5","key":"10.1016\/bs.vh.2025.10.005_bib0042","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1111\/cen.13129","article-title":"Discrepant GH and IGF-I in acromegaly: Meta-analysis","volume":"85","author":"Kanakis","year":"2016","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"1","key":"10.1016\/bs.vh.2025.10.005_bib0043","first-page":"luae225","article-title":"Pituitary gigantism with residual disease treated with lanreotide","volume":"3","author":"Kanley","year":"2024","journal-title":"J Clin Endocrinol Metab Case Rep"},{"issue":"11","key":"10.1016\/bs.vh.2025.10.005_bib0044","doi-asserted-by":"crossref","first-page":"3933","DOI":"10.1210\/jc.2014-2700","article-title":"Acromegaly: An endocrine society clinical practice guideline","volume":"99","author":"Katznelson","year":"2014","journal-title":"J Clin Endocrinol Metab"},{"issue":"5","key":"10.1016\/bs.vh.2025.10.005_bib0045","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1542\/peds.2013-4301","article-title":"Fragile X syndrome: A review of associated medical problems","volume":"134","author":"Kidd","year":"2014","journal-title":"Pediatrics"},{"issue":"5","key":"10.1016\/bs.vh.2025.10.005_bib0046","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1038\/ejhg.2014.162","article-title":"Malan syndrome: Sotos-like overgrowth with de novo NFIX sequence variants and deletions","volume":"23","author":"Klaassens","year":"2015","journal-title":"Eur J Hum Genet"},{"issue":"9","key":"10.1016\/bs.vh.2025.10.005_bib0047","first-page":"590","article-title":"Disorders of puberty: An approach to diagnosis and management","volume":"96","author":"Klein","year":"2017","journal-title":"Am Fam Physician"},{"issue":"4","key":"10.1016\/bs.vh.2025.10.005_bib0048","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/j.ejmg.2015.12.002","article-title":"Two familial microduplications of 15q26.3 causing overgrowth and variable intellectual disability with normal copy number of IGF1R","volume":"59","author":"Leffler","year":"2016","journal-title":"Eur J Med Genet"},{"issue":"5\u20136","key":"10.1016\/bs.vh.2025.10.005_bib0049","first-page":"283","article-title":"McCune-Albright syndrome with GH adenoma: Autopsy case","volume":"24","author":"Liu","year":"2011","journal-title":"J Pediatr Endocrinol Metab"},{"issue":"1","key":"10.1016\/bs.vh.2025.10.005_bib0050","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1186\/s12887-021-02936-1","article-title":"Obesity is a risk factor for central precocious puberty: A case-control study","volume":"21","author":"Liu","year":"2021","journal-title":"BMC Pediatr"},{"issue":"1","key":"10.1016\/bs.vh.2025.10.005_bib0051","first-page":"1","article-title":"Pegvisomant in neurofibromatosis type 1","volume":"65","author":"Main","year":"2006","journal-title":"Horm Res"},{"key":"10.1016\/bs.vh.2025.10.005_bib0052","series-title":"Pituitary disorders of childhood","article-title":"Gigantism and acromegaly","author":"Makri","year":"2019"},{"issue":"5","key":"10.1016\/bs.vh.2025.10.005_bib0053","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1007\/s11102-016-0732-3","article-title":"Octreotide and pegvisomant in pituitary gigantism","volume":"19","author":"Mangupli","year":"2016","journal-title":"Pituitary"},{"key":"10.1016\/bs.vh.2025.10.005_bib0054","article-title":"Overgrowth syndromes\u2014Evaluation, diagnosis, and management","volume":"8","author":"Manor","year":"2020","journal-title":"Front Pediatr"},{"issue":"6","key":"10.1016\/bs.vh.2025.10.005_bib0055","doi-asserted-by":"crossref","first-page":"e2247","DOI":"10.1210\/clinem\/dgaa040","article-title":"Significant benefits of AIP testing and clinical screening in familial isolated and young-onset pituitary tumors","volume":"105","author":"Marques","year":"2020","journal-title":"J Clin Endocrinol Metab"},{"issue":"6","key":"10.1016\/bs.vh.2025.10.005_bib0056","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1111\/cen.13852","article-title":"Coexisting pituitary and non-pituitary gigantism in the same family","volume":"89","author":"Marques","year":"2018","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.1016\/bs.vh.2025.10.005_bib0057","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.yfrne.2018.11.001","article-title":"Pseudoacromegaly","volume":"52","author":"Marques","year":"2019","journal-title":"Front Neuroendocr"},{"issue":"6","key":"10.1016\/bs.vh.2025.10.005_bib0058","doi-asserted-by":"crossref","first-page":"1767","DOI":"10.1210\/clinem\/dgab789","article-title":"Approach to the patient with pseudoacromegaly","volume":"107","author":"Marques","year":"2022","journal-title":"J Clin Endocrinol Metab"},{"issue":"6","key":"10.1016\/bs.vh.2025.10.005_bib0059","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1111\/cen.15053","article-title":"Pseudoacromegaly\u2014A challenging entity in the endocrine clinic: A systematic review","volume":"100","author":"Marques","year":"2024","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"1","key":"10.1016\/bs.vh.2025.10.005_bib0060","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1002\/ajmg.a.36218","article-title":"Overgrowth syndrome associated with a gain-of-function mutation of the natriuretic peptide receptor 2 (NPR2) gene","volume":"164A","author":"Miura","year":"2014","journal-title":"Am J Med Genet A"},{"key":"10.1016\/bs.vh.2025.10.005_bib0061","series-title":"GeneReviews\u00ae","article-title":"Tatton-Brown-Rahman syndrome","author":"Ostrowski","year":"2022"},{"issue":"6","key":"10.1016\/bs.vh.2025.10.005_bib0062","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1159\/000327831","article-title":"Pediatric somatotropinoma: Case and review","volume":"75","author":"Personnier","year":"2011","journal-title":"Horm Res Paediatr"},{"issue":"2","key":"10.1016\/bs.vh.2025.10.005_bib0063","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1515\/JPEM.2005.18.2.171","article-title":"Constitutional delay of growth and puberty: From presentation to final height","volume":"18","author":"Poyrazo\u011flu","year":"2005","journal-title":"J Pediatr Endocrinol Metab"},{"issue":"17","key":"10.1016\/bs.vh.2025.10.005_bib0064","doi-asserted-by":"crossref","first-page":"1382","DOI":"10.1136\/heartjnl-2013-304709","article-title":"Diagnosis and treatment of Marfan syndrome: An update","volume":"100","author":"Radke","year":"2014","journal-title":"Heart"},{"issue":"2","key":"10.1016\/bs.vh.2025.10.005_bib0065","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1530\/eje.1.01956","article-title":"Pegvisomant in pituitary gigantism","volume":"153","author":"Rix","year":"2005","journal-title":"Eur J Endocrinol"},{"issue":"5","key":"10.1016\/bs.vh.2025.10.005_bib0066","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1530\/ERC-15-0320","article-title":"Clinical and genetic characterization of pituitary gigantism: An international collaborative study in 208 patients","volume":"22","author":"Rostomyan","year":"2015","journal-title":"Endocr Relat Cancer"},{"issue":"4","key":"10.1016\/bs.vh.2025.10.005_bib0067","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1007\/s40618-023-02223-z","article-title":"Tall stature and gigantism in transition age: Clinical and genetic aspects\u2014A literature review and recommendations","volume":"47","author":"Sada","year":"2024","journal-title":"J Endocrinol Invest"},{"issue":"3","key":"10.1016\/bs.vh.2025.10.005_bib0068","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1159\/000458525","article-title":"Endocrine long-term follow-up of children with neurofibromatosis type 1 and optic pathway glioma","volume":"87","author":"Sani","year":"2017","journal-title":"Horm Res Paediatr"},{"issue":"4","key":"10.1016\/bs.vh.2025.10.005_bib0069","first-page":"184","article-title":"Five-year follow-up of gigantism treated with octreotide","volume":"61","author":"Schoof","year":"2004","journal-title":"Horm Res"},{"issue":"2","key":"10.1016\/bs.vh.2025.10.005_bib0070","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.jaapos.2009.11.020","article-title":"Optic pathway gliomas in patients with neurofibromatosis type 1: Follow-up of 44 patients","volume":"14","author":"Segal","year":"2010","journal-title":"J Am Assoc Pediatr Ophthalmol Strabismus"},{"issue":"5","key":"10.1016\/bs.vh.2025.10.005_bib0071","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1507\/endocrj.EJ12-0417","article-title":"Lanreotide in Japanese patients with acromegaly or gigantism","volume":"60","author":"Shimatsu","year":"2013","journal-title":"Endocr J"},{"issue":"3","key":"10.1016\/bs.vh.2025.10.005_bib0072","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1227\/01.neu.0000431480.87160.84","article-title":"Long-term serum IGF-1 changes after surgery","volume":"73","author":"Shin","year":"2013","journal-title":"Neurosurgery"},{"key":"10.1016\/bs.vh.2025.10.005_bib0073","series-title":"GeneReviews\u00ae","article-title":"Beckwith-Wiedemann syndrome","author":"Shuman","year":"2000"},{"issue":"12","key":"10.1016\/bs.vh.2025.10.005_bib0074","first-page":"4776","article-title":"Pituitary macroadenoma in a 5-year-old: An early expression of multiple endocrine neoplasia type 1","volume":"85","author":"Stratakis","year":"2000","journal-title":"J Clin Endocrinol Metab"},{"issue":"16","key":"10.1016\/bs.vh.2025.10.005_bib0075","doi-asserted-by":"crossref","first-page":"1204","DOI":"10.1093\/jnci\/dji240","article-title":"Cancer incidence and mortality in men with Klinefelter syndrome: A cohort study","volume":"97","author":"Swerdlow","year":"2005","journal-title":"J Natl Cancer Inst"},{"issue":"7","key":"10.1016\/bs.vh.2025.10.005_bib0076","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1507\/endocrj.EJ16-0624","article-title":"Long-acting pasireotide in Japanese patients","volume":"64","author":"Tahara","year":"2017","journal-title":"Endocr J"},{"issue":"3","key":"10.1016\/bs.vh.2025.10.005_bib0077","first-page":"595","article-title":"Case of McCune-Albright syndrome and pituitary gigantism","volume":"55","author":"Tajima","year":"2008","journal-title":"Endocrinol J"},{"issue":"2","key":"10.1016\/bs.vh.2025.10.005_bib0078","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1086\/432082","article-title":"Genotype-phenotype associations in Sotos syndrome: An analysis of 266 individuals with NSD1 aberrations","volume":"77","author":"Tatton-Brown","year":"2005","journal-title":"Am J Hum Genet"},{"issue":"12","key":"10.1016\/bs.vh.2025.10.005_bib0079","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.18632\/oncotarget.385","article-title":"Germline mutations in the oncogene EZH2 cause weaver syndrome and increased human height","volume":"2","author":"Tatton-Brown","year":"2011","journal-title":"Oncotarget"},{"issue":"25","key":"10.1016\/bs.vh.2025.10.005_bib0080","doi-asserted-by":"crossref","first-page":"2363","DOI":"10.1056\/NEJMoa1408028","article-title":"Gigantism and acromegaly due to Xq26 microduplications and GPR101 mutation","volume":"371","author":"Trivellin","year":"2014","journal-title":"N Engl J Med"},{"issue":"5","key":"10.1016\/bs.vh.2025.10.005_bib0081","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1530\/ERC-15-0320","article-title":"Clinical and genetic characterization of pituitary gigantism: An international collaborative study in 208 patients","volume":"22","author":"Trivellin","year":"2015","journal-title":"Endocr Relat Cancer"},{"key":"10.1016\/bs.vh.2025.10.005_bib0082","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2023.1166076","article-title":"Germline loss-of-function PAM variants are enriched in subjects with pituitary hypersecretion","volume":"14","author":"Trivellin","year":"2023","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"4","key":"10.1016\/bs.vh.2025.10.005_bib0083","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1097\/PAS.0b013e31815ade45","article-title":"Pituitary tumors and hyperplasia in multiple endocrine neoplasia type 1 syndrome (MEN1): A case-control study","volume":"32","author":"Trouillas","year":"2008","journal-title":"Am J Surg Pathol"},{"issue":"7","key":"10.1016\/bs.vh.2025.10.005_bib0084","doi-asserted-by":"crossref","first-page":"2404","DOI":"10.1210\/jc.2012-1274","article-title":"Somatic GNAS mutation causes widespread and diffuse pituitary disease in acromegalic patients with McCune-Albright syndrome","volume":"97","author":"Vortmeyer","year":"2012","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/bs.vh.2025.10.005_bib0085","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2021.672394","article-title":"Clinical characteristics and management of patients with McCune-Albright syndrome with GH excess and precocious puberty: A case series and literature review","volume":"12","author":"Zhai","year":"2021","journal-title":"Front Endocrinol (Lausanne)"}],"container-title":["Vitamins and Hormones","Growth Hormone and Related Disorders: From Clinics to Diagnosis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0083672925000561?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0083672925000561?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,28]],"date-time":"2026-03-28T09:02:10Z","timestamp":1774688530000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0083672925000561"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026]]},"ISBN":["9780443431722"],"references-count":84,"URL":"https:\/\/doi.org\/10.1016\/bs.vh.2025.10.005","relation":{},"ISSN":["0083-6729"],"issn-type":[{"value":"0083-6729","type":"print"}],"subject":[],"published":{"date-parts":[[2026]]}}}